alea-institute/kl3m-data-sample-004-shuffled huggingface dataset:
Exhibit 10.26.2

2nd AMENDMENT TO THE DISTRIBUTION AGREEMENT

This Second Amendment to the Distribution Agreement ("AGREEMENT"), is entered into as of October 8, 1999 by and between MedImmune, Inc., a Delaware
Corporation, having its principal place of business at 35 West Watkins Mill Road, Gaithersburg, MD 20878 ("MEDIMMUNE") and Abbott International, Ltd., a Delaware Corporation, having its
principal place of business at 200 Abbott Park Road, Abbot Park, IL 60064.

WITNESSETH

WHEREAS, MEDIMMUNE and Abbott International, Ltd. entered into a Distribution Agreement as of December 1, 1997 that was subsequently amended on
April 28, 1999 (Distribution Agreement and Amendment collectively the "DISTRIBUTION AGREEMENT").

WHEREAS,
the parties desire to further amend the DISTRIBUTION AGREEMENT;

1.DEFINITIONS



2.AMENDMENT







---



3.EFFECT



---



IN
WITNESS WHEREOF, the parties have each caused this AGREEMENT to be signed and delivered by its duly authorized officer or representative as indicated below.

|ABBOTT INTERNATIONAL, LTD |                                            | MEDIMMUNE, INC.
|------------------------- | ------------------------------------------ | ---------------
|By:                       | /s/WILLIAM G. DEMPSEYWilliam G. Dempsey    |                
|Name:                     | William G. Dempsey                         |                
|Title:                    | Senior Vice President
Abbott International |                

JOINDER

The undersigned, Abbott Laboratories, an Illinois Corporation, hereby consents to this AGREEMENT and joins in the execution of this AGREEMENT for the purpose of
obligating itself to the obligations and undertakings of Abbott International Ltd., as set forth in this AGREEMENT.

|ABBOTT LABORATORIES |                                                                                                                                                 
|------------------- | ------------------------------------------------------------------------------------------------------------------------------------------------
|By:                 | /s/WILLIAM G. DEMPSEYName: William G. Dempsey
Title: Senior Vice President, Abbott International, Abbott Laboratories
Dated:    October 13, 1999

---

QuickLinks
-78.0 -77.8 -77.6 -77.4 -77.2 -77.0 -76.8 -76.6

 38.4

 38.6

 38.8

 39.0

 39.2

★

▲

▲

▲

▲

★ ▲ ▲ ▲ ▲

 500

 1000

 1500

 100

18 12 06 00

08/25

NOAA HYSPLIT MODEL

 Backward trajectory ending at 2300 UTC 25 Aug 06

 EDAS Meteorological Data

Source

★ at 38.86 N 77.06 W Meters AGL
#### SELLERS v. GIBSON.

No. 8712.

Court of Civil Appeals of Texas. San Antonio.

Jan. 13, 1932.

Rehearing Denied Eeb. 17, 1932.

Sid B. Malone, of Beeville, for appellant.

W. G. Gayle, of Beeville, and O. C. Carsner, of Victoria, for appellee.

FLY, C. J.

This is a suit by appellee to recover freight money due him by appellant for hauling cdt-ton bales on the truck of appellee from various points to Houston, in the sum of $800. The suit was originally filed in Victoria county, and, upon a plea of privilege, the venue was changed to Live Oak county, and then by agreement of parties the venue was changed to Bee county, where it was tried. Judgment was rendered in favor of appellee for $800 as against appellant and his sureties on a re-plevin bond, three trucks of appellant having been attached by appellee. The petition with its exhibits covers 47 pages of the record.

The exhibits were not necessary and merely added to the costs of suit, and the court should have granted the motion of appellant to strike them from the petition. The only tenable objection to the exhibits was the increased cost, and the transcript shows that nearly half of the petition is made up of the exhibits. The error can be corrected by repaying the costs on the transcript. On a pro rata basis, the exhibits were placed in the transcript at a cost of $32.20, which appellant should not be forced to pay.

Appellant contracted with appellee to pay him for hauling cotton at the rate fixed by the railroad commission of Texas. The exhibits attached to the petition were used to establish the rate fixed by the commission. Appellee swore that he obtained the exhibits from the railroad commission and verified them in'every respect. Article 6478, Revised Statutes, provides that printed copies of the Tates and regulations of the railroad commission should be admissible in evidence, and further provides that a substantial compliance with the terms of the statute would be sufficient. A mimeograph copy of the rates would be a substantial compliance with the statute.

In place of'assignments of error, appellant has in his brief what he calls “Appellant’s claimed errors of the trial Court.” We overrule them.

The judgment is affirmed.
OPEN PLAN SYSTEMS, INC.

          EXHIBIT 11 - Statement Re: Computation of Per Share Earnings



                                                       Three Months Ended
                                                            March 31,
                                                      2001            2000
                                                --------------------------------

   Weighted average shares outstanding
      during the period                                 4,339            4,403

   Assumed exercise of options less assumed
      acquisition of shares                                 0                2
                                                --------------------------------
   Total                                                4,339            4,405
                                                ================================


   Net (loss) income used in computation          $      (981)     $       124
                                                ================================

   (Loss) income per common share                 $      (.23)     $       .03
                                                ================================
Exhibit 31.2

CERTIFICATION PURSUANT TO RULE 13A-14(a) OR 15D-14(a) OF THE SECURITIES
EXCHANGE ACT OF 1934, AS ADOPTED PURSUANT TO SECTION 302 OF THE
SARBANES-OXLEY ACT OF 2002

I, William J. Donovan, certify that:

1.

I have reviewed this report on Form 10-KSB of Guardian Technologies International, Inc.;



2.

Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report;



3.

Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the small business issuer as of, and for, the periods presented in this report;



4.

The small business issuer's other certifying officer(s) and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) for the small business issuer and have:

(a)

designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the small business issuer, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared;



(b)

evaluated the effectiveness of the small business issuer's disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation; and



(c)

disclosed in this report any change in the small business issuer's internal control over financial reporting that occurred during the small business issuer's most recent fiscal quarter (the small business issuer's fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to affect, the small business issuer's internal control over financial reporting; and



5.

The small business issuer's other certifying officer(s) and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the small business issuer's auditors and the audit committee of registrant's board of directors (or persons performing the equivalent functions):

(a)

all significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the small business issuer's ability to record, process, summarize and report financial information; and



(b)

any fraud, whether or not material, that involves management or other employees who have a significant role in the small business issuer's internal control over financial reporting.







Date: May 13, 2005

Signed:

/s/ William J. Donovan

Name: William J. Donovan

Title: Chief Financial Officer
##### 



Exhibit 31.1
 Rule 13a-14(a)/15d-14(a) Certification
(Principal Executive Officer)
  1.
    
    I have reviewed this Quarterly Report on Form 10-Q for the quarterly period
ended March 31, 2006 of AirNet Systems, Inc.;2.
    
    Based on my knowledge, this report does not contain any untrue statement of a
material fact or omit to state a material fact necessary to make the statements made,
in light of the circumstances under which such statements were made, not misleading
with respect to the period covered by this report;3.
    
    Based on my knowledge, the financial statements, and other financial
information included in this report, fairly present in all material respects the
financial condition, results of operations and cash flows of the registrant as of, and
for, the periods presented in this report;4.
    
    The registrants other certifying officer and I are responsible for
establishing and maintaining disclosure controls and procedures (as defined in Exchange
Act Rules 13a-15(e) and 15d-15(e)) for the registrant and have:
 a.
    
    Designed such disclosure controls and procedures, or caused such
disclosure controls and procedures to be designed under our supervision, to
ensure that material information relating to the registrant, including its
consolidated subsidiaries, is made known to us by others within those entities,
particularly during the period in which this report is being prepared;b.
    
    [Reserved];c.
    
    Evaluated the effectiveness of the registrants disclosure
controls and procedures and presented in this report our conclusions about the
effectiveness of the disclosure controls and procedures, as of the end of the
period covered by this report based on such evaluation; andd.
    
    Disclosed in this report any change in the registrants
internal control over financial reporting that occurred during the registrants
most recent fiscal quarter that has materially affected, or is reasonably
likely to materially affect, the registrants internal control over financial
reporting; and
 5.
    
    The registrants other certifying officer and I have disclosed, based on
our most recent evaluation of internal control over financial reporting, to the
registrants auditors and the audit committee of the registrants board of directors
(or persons performing the equivalent functions):
 a.
    
    All significant deficiencies and material weaknesses in the
design or operation of internal control over financial reporting which are
reasonably likely to adversely affect the registrants ability to record,
process, summarize and report financial information; andb.
    
    Any fraud, whether or not material, that involves management or
other employees who have a significant role in the registrants internal
control over financial reporting.
 Dated: May 15, 2006
    
    By:
    
    /s/ Joel E. BiggerstaffPrinted Name: Joel E. BiggerstaffTitle: Chairman of the Board, Chief Executive Officer and President
 26
<PAGE>   1
                                                           EXHIBIT 23 - CONSENTS


                          INDEPENDENT AUDITORS' CONSENT


We consent to the incorporation by reference in the Century Federal Profit
Sharing and 401(k) Plan Registration Statement No. 33-43010 on Form S-8, the
1992 Long Term Incentive Plan Registration Statement No. 33-48077 on Form S-8,
the 1994 Long Term Incentive Plan Registration Statement No. 33-90098 on Form
S-8 and the 1994 Directors Stock Option Plan Registration Statement No. 33-90096
on Form S-8 of our report dated March 8, 1995, appearing in this Annual Report
on Form 10-K of CENFED Financial Corporation for the year ended December 31,
1996.

                                                           Deloitte & Touche LLP

Los Angeles, California
March 18, 1997


<PAGE>   2
                         CONSENT OF INDEPENDENT AUDITORS

The Board of Directors
CENFED Financial Corporation

We consent to the incorporation by reference in the registration statements (No.
33-43010, No. 33-48077, NO. 33-90098 and No. 33-90096) on Form S-8 of CENFED
Financial Corporation of our report dated January 27, 1997, relating to the
consolidated statements of financial condition of CENFED Financial Corporation
and subsidiaries as of December 31, 1996 and 1995, and the related consolidated
statements of operations, stockholders' equity and cash flows for each of the
years in the two-year period ended December 31, 1996, which report appears in
the December 31, 1996 annual report on Form 10-K of CENFED Financial
Corporation.


                                                           KPMG Peat Marwick LLP

Los Angeles, California
March 24, 1997
<PAGE>

EXHIBIT 32.1
                            CERTIFICATION PURSUANT TO
                             18 U.S.C. SECTION 1350
                             AS ADOPTED PURSUANT TO
                  SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002

In connection with the Quarterly Report of Global Digital Solutions, Inc. (the
"Company") on Form 10-QSB for the period ending September 30, 2004 as filed with
the Securities and Exchange Commission on the date hereof (the "Report"), I,
William J. Delgado, Chief Executive Officer and Chief Financial Officer of the
Company, certify, pursuant to 18 U.S.C. ss.1350, as adopted pursuant to ss.906
of the Sarbanes-Oxley Act of 2002, that to my knowledge:

         1.       The Report fully complies with the requirements of section
                  13(a) or 15(d) of the Securities Exchange Act of 1934 and

         2.       The information contained in the Report fairly presents, in
                  all material respects, the financial condition and results of
                  operations of the Company.

                                               /s/  William J. Delgado
                                               ---------------------------------
                                               William J. Delgado
                                               Chief Executive Officer and
                                               Chief Financial Officer

Date:  December 14, 2004

A signed original of this written statement required by Section 906 has been
provided to the Company and will be retained by the Company and furnished to the
Securities and Exchange Commission or its staff upon request.
CERTIFICATION OF THE CEO AND CFO PURSUANT TO 18 U.S.C. SECTION 1350 AS ADOPTED
PURSUANT TO SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002

In connection with the quarterly report of Auxilio, Inc. and Subsidiary (the
"Company") on Form 10-QSB for the quarter ending September 30, 2005 as filed
with the Securities and Exchange Commission on the date hereof (the "Report"),
we, Joseph Flynn, Chief Executive Officer and Paul T. Anthony Principal
Financial Officer of the Company, certify, pursuant to 18 U.S.C. Section 1350,
as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, that to
the best of my knowledge:


(1) The Report fully complies with the requirements of section 13(a) or 15(d) of
the Securities Exchange Act of 1934; and


(2) The information contained in the Report fairly presents, in all material
respects the financial condition and results of the Company.



Date:  November 18, 2005
                            By:           /s/ Joseph Flynn
                                ---------------------------------------------
                                 Joseph Flynn, Chief Executive Officer




                            By:           /s/ Paul T. Anthony
                                ---------------------------------------------
                                 Paul T. Anthony, Principal Financial Officer
<TABLE> <S> <C>


<ARTICLE>                     5
       
<S>                             <C>
<PERIOD-TYPE>                   9-MOS
<FISCAL-YEAR-END>                              Dec-31-1997
<PERIOD-START>                                 Jan-01-1997
<PERIOD-END>                                   Sep-30-1997
<CASH>                                          15,737,474
<SECURITIES>                                     3,961,633
<RECEIVABLES>                                            0
<ALLOWANCES>                                             0
<INVENTORY>                                              0
<CURRENT-ASSETS>                                19,847,321
<PP&E>                                           1,866,684
<DEPRECIATION>                                     798,487
<TOTAL-ASSETS>                                  21,274,350
<CURRENT-LIABILITIES>                            1,781,053
<BONDS>                                                  0
<PREFERRED-MANDATORY>                                    0
<PREFERRED>                                              0
<COMMON>                                            85,029
<OTHER-SE>                                      19,408,268
<TOTAL-LIABILITY-AND-EQUITY>                    21,274,350
<SALES>                                             29,313
<TOTAL-REVENUES>                                    29,313
<CGS>                                                    0
<TOTAL-COSTS>                                   10,536,573
<OTHER-EXPENSES>                                         0
<LOSS-PROVISION>                                         0
<INTEREST-EXPENSE>                                 939,810
<INCOME-PRETAX>                                (9,567,450)
<INCOME-TAX>                                             0
<INCOME-CONTINUING>                            (9,567,450)
<DISCONTINUED>                                           0
<EXTRAORDINARY>                                          0
<CHANGES>                                                0
<NET-INCOME>                                   (9,567,450)
<EPS-PRIMARY>                                       (1.14)
<EPS-DILUTED>                                       (1.14)
        


</TABLE>
[Federal Register Volume 65, Number 231 (Thursday, November 30, 2000)]
[Notices]
[Page 71326]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 00-30459]


-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES

National Institutes of Health


National Cancer Institute, Notice of Closed Meeting

    Pursuant to section 10(d) of the Federal Advisory Committee Act, as 
amended (5 U.S.C. Appendix 2), notice is hereby given of the following 
meeting.
    The meeting will be closed to the public in accordance with the 
provisions set forth in sections 552b(c)(4) and 552b(c)(6), Title 5 
U.S.C., as amended. The grant applications and the discussions could 
disclose confidential trade secrets or commercial property such as 
patentable material, and personal information concerning individuals 
associated with the grant applications, the disclosure of which would 
constitute a clearly unwarranted invasion of personal privacy.

    Name of Committee: National Cancer Institute Special Emphasis 
Panel Measurement of pO2 in tissues in vivo and in vitro.
    Date: December 10-12, 2000.
    Time: 7 p.m. to 12 p.m.
    Agenda: To review and evaluate grant applications.
    Place: The Hanover Inn, The corner of Main Street and East 
Wheelock, Hanover, NH 03755.
    Contact Person: Peter J. Wirth, Scientific Review Administrator, 
Grants Review Branch, Division of Extramural Activities, National 
Cancer Institute, 6116 Executive Boulevard, Room 8021, Bethesda, MD 
20892, 301/496-7565.
    This notice is being published less than 15 days prior to the 
meeting due to the timing limitations imposed by the review and 
funding cycle.

(Catalogue of Federal Domestic Assistance program Nos. 93.392, 
Cancer Construction; 93.393, Cancer Cause and Prevention Research; 
93.394, Cancer Detection and Diagnosis Research; 93.395, Cancer 
Treatment Research; 93.396, Cancer Biology Research; 93.397, Cancer 
Centers Support; 93.398, Cancer Research Manpower; 93.399, Cancer 
Control, National Institutes of Health, HHS)

    Dated: November 21, 2000.
LaVerne Y. Stringfield,
Director, Office of Federal Advisory Committee Policy.
[FR Doc. 00-30459 Filed 11-29-00; 8:45 am]
BILLING CODE 4140-01-M
<TABLE> <S> <C>

<ARTICLE> 5
<MULTIPLIER> 1,000

<S>                             <C>
<PERIOD-TYPE>                   9-MOS
<FISCAL-YEAR-END>                          DEC-31-1999
<PERIOD-START>                             JAN-01-1999
<PERIOD-END>                               SEP-30-1999
<CASH>                                            7785
<SECURITIES>                                     37779
<RECEIVABLES>                                    42289
<ALLOWANCES>                                      1781
<INVENTORY>                                       1177
<CURRENT-ASSETS>                                 90435
<PP&E>                                           19527
<DEPRECIATION>                                    9455
<TOTAL-ASSETS>                                  115133
<CURRENT-LIABILITIES>                            28622
<BONDS>                                              0
<PREFERRED-MANDATORY>                                0
<PREFERRED>                                          0
<COMMON>                                         52386
<OTHER-SE>                                       28613
<TOTAL-LIABILITY-AND-EQUITY>                    115133
<SALES>                                          99517
<TOTAL-REVENUES>                                 99517
<CGS>                                            17041
<TOTAL-COSTS>                                    44915
<OTHER-EXPENSES>                                 11887
<LOSS-PROVISION>                                     0
<INTEREST-EXPENSE>                                 936
<INCOME-PRETAX>                                  17761
<INCOME-TAX>                                      6523
<INCOME-CONTINUING>                              11238
<DISCONTINUED>                                       0
<EXTRAORDINARY>                                      0
<CHANGES>                                            0
<NET-INCOME>                                     11238
<EPS-BASIC>                                        .73
<EPS-DILUTED>                                      .72


</TABLE>